High-dose ivermectin in malaria and other parasitic diseases: a new step in the development of a neglected drug
Parasite, 25 (2018) 33
Published online: 2018-07-16
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
459 (2023)
https://doi.org/10.1007/978-3-031-26070-4_30
Sarcoptes Infestation. What Is Already Known, and What Is New about Scabies at the Beginning of the Third Decade of the 21st Century?
Katarzyna Talaga-ĆwiertniaPathogens 10 (7) 868 (2021)
https://doi.org/10.3390/pathogens10070868
Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine
Na Li, Huanni Li, Ya Wang, Lanqin Cao and Xianquan ZhanEPMA Journal 11 (4) 661 (2020)
https://doi.org/10.1007/s13167-020-00224-z
The public health control of scabies: priorities for research and action
Daniel Engelman, Paul T Cantey, Michael Marks, Anthony W Solomon, Aileen Y Chang, Olivier Chosidow, Wendemagegn Enbiale, Dirk Engels, Roderick J Hay, David Hendrickx, Peter J Hotez, John M Kaldor, Mike Kama, Charles D Mackenzie, James S McCarthy, Diana L Martin, Birhan Mengistu, Toby Maurer, Nebiyu Negussu, Lucia Romani, Oliver Sokana, Margot J Whitfeld, L Claire Fuller and Andrew C SteerThe Lancet 394 (10192) 81 (2019)
https://doi.org/10.1016/S0140-6736(19)31136-5